English
简体中文
Total: £ 56.28
Published Date: 2025-09-25 | Pages: 100 | Tables: 92 | Pharma & Healthcare
The global OTC Anti-Infective Products market size was US$ 14230 million in 2024 and is forecast to a readjusted size of US$ 17930 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on OTC Anti-Infective Products market competitiveness, regional economic performance, and supply chain configurations.
Anti-infectives are medicines that work to prevent or treat infections. Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
The OTC anti-infective products market is driven by the growing consumer demand for accessible and affordable healthcare solutions. With increasing awareness of self-care and the rising prevalence of minor infections like cuts, burns, and fungal conditions, consumers are turning to OTC products for quick relief and convenience. Additionally, the expansion of retail pharmacy chains and e-commerce platforms has improved the availability of OTC anti-infective products globally, further boosting market growth. Innovations in formulations, such as faster-acting and longer-lasting products, also contribute to market demand.
Despite its growth, the market faces challenges, including the risk of misuse or overuse of OTC anti-infective products, which can lead to antimicrobial resistance (AMR). Regulatory scrutiny is also increasing to ensure product safety and efficacy, which may delay product approvals and raise costs for manufacturers. Moreover, competition from alternative treatments, such as natural remedies or prescription medications, may limit the market potential for OTC anti-infective products, particularly in regions with stricter healthcare regulations.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
The global OTC Anti-Infective Products market is strategically segmented by company, region (country), by Type, and by Sales Channel. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Sales Channel for 2020-2031.
Market Segmentation
By Company:
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Gilead Sciences
Pfizer
Bausch Health
Astellas Pharma
Roche
By Type: (Dominant Segment vs High-Margin Innovation)
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bayer in Europe)
- Emerging Product Trends: Antifungal adoption vs. Antibacterial premiumization
- Demand-Side Dynamics: Hospital Pharmacies growth in China vs. Retail Pharmacies potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of OTC Anti-Infective Products market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Antibacterial in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacies in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Antifungal dominance in Europe vs. Antibacterial demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 OTC Anti-Infective Products Product Scope
1.2 OTC Anti-Infective Products by Type
1.2.1 Global OTC Anti-Infective Products Sales by Type (2020 & 2024 & 2031)
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 OTC Anti-Infective Products by Sales Channel
1.3.1 Global OTC Anti-Infective Products Sales Comparison by Sales Channel (2020 & 2024 & 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Anti-Infective Products Market Estimates and Forecasts (2020-2031)
1.4.1 Global OTC Anti-Infective Products Market Size in Value Growth Rate (2020-2031)
1.4.2 Global OTC Anti-Infective Products Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global OTC Anti-Infective Products Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global OTC Anti-Infective Products Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global OTC Anti-Infective Products Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global OTC Anti-Infective Products Sales Market Share by Region (2020-2025)
2.2.2 Global OTC Anti-Infective Products Revenue Market Share by Region (2020-2025)
2.3 Global OTC Anti-Infective Products Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global OTC Anti-Infective Products Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America OTC Anti-Infective Products Market Size and Prospective (2020-2031)
2.4.2 Europe OTC Anti-Infective Products Market Size and Prospective (2020-2031)
2.4.3 China OTC Anti-Infective Products Market Size and Prospective (2020-2031)
2.4.4 India OTC Anti-Infective Products Market Size and Prospective (2020-2031)
2.4.5 Japan OTC Anti-Infective Products Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global OTC Anti-Infective Products Historic Market Review by Type (2020-2025)
3.1.1 Global OTC Anti-Infective Products Sales by Type (2020-2025)
3.1.2 Global OTC Anti-Infective Products Revenue by Type (2020-2025)
3.1.3 Global OTC Anti-Infective Products Price by Type (2020-2025)
3.2 Global OTC Anti-Infective Products Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2026-2031)
3.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2026-2031)
3.2.3 Global OTC Anti-Infective Products Price Forecast by Type (2026-2031)
3.3 Different Types OTC Anti-Infective Products Representative Players
4 Global Market Size by Sales Channel
4.1 Global OTC Anti-Infective Products Historic Market Review by Sales Channel (2020-2025)
4.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2020-2025)
4.1.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2020-2025)
4.1.3 Global OTC Anti-Infective Products Price by Sales Channel (2020-2025)
4.2 Global OTC Anti-Infective Products Market Estimates and Forecasts by Sales Channel (2026-2031)
4.2.1 Global OTC Anti-Infective Products Sales Forecast by Sales Channel (2026-2031)
4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Sales Channel (2026-2031)
4.2.3 Global OTC Anti-Infective Products Price Forecast by Sales Channel (2026-2031)
4.3 New Sources of Growth in OTC Anti-Infective Products Application
5 Competition Landscape by Players
5.1 Global OTC Anti-Infective Products Sales by Players (2020-2025)
5.2 Global Top OTC Anti-Infective Products Players by Revenue (2020-2025)
5.3 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2024)
5.4 Global OTC Anti-Infective Products Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
5.7 Global Key Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America OTC Anti-Infective Products Sales by Company
6.1.1.1 North America OTC Anti-Infective Products Sales by Company (2020-2025)
6.1.1.2 North America OTC Anti-Infective Products Revenue by Company (2020-2025)
6.1.2 North America OTC Anti-Infective Products Sales Breakdown by Type (2020-2025)
6.1.3 North America OTC Anti-Infective Products Sales Breakdown by Sales Channel (2020-2025)
6.1.4 North America OTC Anti-Infective Products Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe OTC Anti-Infective Products Sales by Company
6.2.1.1 Europe OTC Anti-Infective Products Sales by Company (2020-2025)
6.2.1.2 Europe OTC Anti-Infective Products Revenue by Company (2020-2025)
6.2.2 Europe OTC Anti-Infective Products Sales Breakdown by Type (2020-2025)
6.2.3 Europe OTC Anti-Infective Products Sales Breakdown by Sales Channel (2020-2025)
6.2.4 Europe OTC Anti-Infective Products Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China OTC Anti-Infective Products Sales by Company
6.3.1.1 China OTC Anti-Infective Products Sales by Company (2020-2025)
6.3.1.2 China OTC Anti-Infective Products Revenue by Company (2020-2025)
6.3.2 China OTC Anti-Infective Products Sales Breakdown by Type (2020-2025)
6.3.3 China OTC Anti-Infective Products Sales Breakdown by Sales Channel (2020-2025)
6.3.4 China OTC Anti-Infective Products Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India OTC Anti-Infective Products Sales by Company
6.4.1.1 India OTC Anti-Infective Products Sales by Company (2020-2025)
6.4.1.2 India OTC Anti-Infective Products Revenue by Company (2020-2025)
6.4.2 India OTC Anti-Infective Products Sales Breakdown by Type (2020-2025)
6.4.3 India OTC Anti-Infective Products Sales Breakdown by Sales Channel (2020-2025)
6.4.4 India OTC Anti-Infective Products Major Customer
6.4.5 India Market Trend and Opportunities
6.5 Japan Market: Players, Segments, Downstream and Major Customers
6.5.1 Japan OTC Anti-Infective Products Sales by Company
6.5.1.1 Japan OTC Anti-Infective Products Sales by Company (2020-2025)
6.5.1.2 Japan OTC Anti-Infective Products Revenue by Company (2020-2025)
6.5.2 Japan OTC Anti-Infective Products Sales Breakdown by Type (2020-2025)
6.5.3 Japan OTC Anti-Infective Products Sales Breakdown by Sales Channel (2020-2025)
6.5.4 Japan OTC Anti-Infective Products Major Customer
6.5.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Bayer
7.1.1 Bayer Company Information
7.1.2 Bayer Business Overview
7.1.3 Bayer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Bayer OTC Anti-Infective Products Products Offered
7.1.5 Bayer Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Business Overview
7.2.3 GSK OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GSK OTC Anti-Infective Products Products Offered
7.2.5 GSK Recent Development
7.3 Teva
7.3.1 Teva Company Information
7.3.2 Teva Business Overview
7.3.3 Teva OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Teva OTC Anti-Infective Products Products Offered
7.3.5 Teva Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Johnson & Johnson OTC Anti-Infective Products Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 NOVARTIS
7.5.1 NOVARTIS Company Information
7.5.2 NOVARTIS Business Overview
7.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.5.4 NOVARTIS OTC Anti-Infective Products Products Offered
7.5.5 NOVARTIS Recent Development
7.6 MYLAN
7.6.1 MYLAN Company Information
7.6.2 MYLAN Business Overview
7.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.6.4 MYLAN OTC Anti-Infective Products Products Offered
7.6.5 MYLAN Recent Development
7.7 Sun Pharma
7.7.1 Sun Pharma Company Information
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Sun Pharma OTC Anti-Infective Products Products Offered
7.7.5 Sun Pharma Recent Development
7.8 CR SANJIU
7.8.1 CR SANJIU Company Information
7.8.2 CR SANJIU Business Overview
7.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.8.4 CR SANJIU OTC Anti-Infective Products Products Offered
7.8.5 CR SANJIU Recent Development
7.9 Cipla
7.9.1 Cipla Company Information
7.9.2 Cipla Business Overview
7.9.3 Cipla OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Cipla OTC Anti-Infective Products Products Offered
7.9.5 Cipla Recent Development
7.10 Lingrui
7.10.1 Lingrui Company Information
7.10.2 Lingrui Business Overview
7.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Lingrui OTC Anti-Infective Products Products Offered
7.10.5 Lingrui Recent Development
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Information
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Gilead Sciences OTC Anti-Infective Products Products Offered
7.11.5 Gilead Sciences Recent Development
7.12 Pfizer
7.12.1 Pfizer Company Information
7.12.2 Pfizer Business Overview
7.12.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Pfizer OTC Anti-Infective Products Products Offered
7.12.5 Pfizer Recent Development
7.13 Bausch Health
7.13.1 Bausch Health Company Information
7.13.2 Bausch Health Business Overview
7.13.3 Bausch Health OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Bausch Health OTC Anti-Infective Products Products Offered
7.13.5 Bausch Health Recent Development
7.14 Astellas Pharma
7.14.1 Astellas Pharma Company Information
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Astellas Pharma OTC Anti-Infective Products Products Offered
7.14.5 Astellas Pharma Recent Development
7.15 Roche
7.15.1 Roche Company Information
7.15.2 Roche Business Overview
7.15.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Roche OTC Anti-Infective Products Products Offered
7.15.5 Roche Recent Development
8 OTC Anti-Infective Products Manufacturing Cost Analysis
8.1 OTC Anti-Infective Products Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of OTC Anti-Infective Products
8.4 OTC Anti-Infective Products Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 OTC Anti-Infective Products Distributors List
9.3 OTC Anti-Infective Products Customers
10 OTC Anti-Infective Products Market Dynamics
10.1 OTC Anti-Infective Products Industry Trends
10.2 OTC Anti-Infective Products Market Drivers
10.3 OTC Anti-Infective Products Market Challenges
10.4 OTC Anti-Infective Products Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global OTC Anti-Infective Products Sales (US$ Million) Comparison by Sales Channel (2020 & 2024 & 2031)
Table 3. Global Market OTC Anti-Infective Products Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global OTC Anti-Infective Products Sales (M Units) by Region (2020-2025)
Table 5. Global OTC Anti-Infective Products Sales Market Share by Region (2020-2025)
Table 6. Global OTC Anti-Infective Products Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global OTC Anti-Infective Products Revenue Share by Region (2020-2025)
Table 8. Global OTC Anti-Infective Products Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global OTC Anti-Infective Products Sales Market Share Forecast by Region (2026-2031)
Table 10. Global OTC Anti-Infective Products Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global OTC Anti-Infective Products Revenue Share Forecast by Region (2026-2031)
Table 12. Global OTC Anti-Infective Products Sales by Type (M Units) & (2020-2025)
Table 13. Global OTC Anti-Infective Products Sales Share by Type (2020-2025)
Table 14. Global OTC Anti-Infective Products Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global OTC Anti-Infective Products Price by Type (US$/Unit) & (2020-2025)
Table 16. Global OTC Anti-Infective Products Sales by Type (M Units) & (2026-2031)
Table 17. Global OTC Anti-Infective Products Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global OTC Anti-Infective Products Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global OTC Anti-Infective Products Sales by Sales Channel (M Units) & (2020-2025)
Table 21. Global OTC Anti-Infective Products Sales Share by Sales Channel (2020-2025)
Table 22. Global OTC Anti-Infective Products Revenue by Sales Channel (US$ Million) & (2020-2025)
Table 23. Global OTC Anti-Infective Products Price by Sales Channel (US$/Unit) & (2020-2025)
Table 24. Global OTC Anti-Infective Products Sales by Sales Channel (M Units) & (2026-2031)
Table 25. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (US$ Million) & (2026-2031)
Table 26. Global OTC Anti-Infective Products Price by Sales Channel (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in OTC Anti-Infective Products Application
Table 28. Global OTC Anti-Infective Products Sales by Company (M Units) & (2020-2025)
Table 29. Global OTC Anti-Infective Products Sales Share by Company (2020-2025)
Table 30. Global OTC Anti-Infective Products Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global OTC Anti-Infective Products Revenue Share by Company (2020-2025)
Table 32. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2024)
Table 33. Global Market OTC Anti-Infective Products Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of OTC Anti-Infective Products, Product Type & Application
Table 36. Global Key Manufacturers of OTC Anti-Infective Products, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 39. North America OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 40. North America OTC Anti-Infective Products Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 42. North America OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 43. North America OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 44. North America OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 45. North America OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Table 46. Europe OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 47. Europe OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 48. Europe OTC Anti-Infective Products Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 50. Europe OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 51. Europe OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 52. Europe OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 53. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Table 54. China OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 55. China OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 56. China OTC Anti-Infective Products Revenue by Company (2020-2025) & (US$ Million)
Table 57. China OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 58. China OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 59. China OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 60. China OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 61. China OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Table 62. India OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 63. India OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 64. India OTC Anti-Infective Products Revenue by Company (2020-2025) & (US$ Million)
Table 65. India OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 66. India OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 67. India OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 68. India OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 69. India OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Table 70. Japan OTC Anti-Infective Products Sales by Company (2020-2025) & (M Units)
Table 71. Japan OTC Anti-Infective Products Sales Market Share by Company (2020-2025)
Table 72. Japan OTC Anti-Infective Products Revenue by Company (2020-2025) & (US$ Million)
Table 73. Japan OTC Anti-Infective Products Revenue Market Share by Company (2020-2025)
Table 74. Japan OTC Anti-Infective Products Sales by Type (2020-2025) & (M Units)
Table 75. Japan OTC Anti-Infective Products Sales Market Share by Type (2020-2025)
Table 76. Japan OTC Anti-Infective Products Sales by Sales Channel (2020-2025) & (M Units)
Table 77. Japan OTC Anti-Infective Products Sales Market Share by Sales Channel (2020-2025)
Table 78. Bayer Company Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bayer OTC Anti-Infective Products Product
Table 82. Bayer Recent Development
Table 83. GSK Company Information
Table 84. GSK Description and Business Overview
Table 85. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. GSK OTC Anti-Infective Products Product
Table 87. GSK Recent Development
Table 88. Teva Company Information
Table 89. Teva Description and Business Overview
Table 90. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Teva OTC Anti-Infective Products Product
Table 92. Teva Recent Development
Table 93. Johnson & Johnson Company Information
Table 94. Johnson & Johnson Description and Business Overview
Table 95. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Johnson & Johnson OTC Anti-Infective Products Product
Table 97. Johnson & Johnson Recent Development
Table 98. NOVARTIS Company Information
Table 99. NOVARTIS Description and Business Overview
Table 100. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. NOVARTIS OTC Anti-Infective Products Product
Table 102. NOVARTIS Recent Development
Table 103. MYLAN Company Information
Table 104. MYLAN Description and Business Overview
Table 105. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. MYLAN OTC Anti-Infective Products Product
Table 107. MYLAN Recent Development
Table 108. Sun Pharma Company Information
Table 109. Sun Pharma Description and Business Overview
Table 110. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Sun Pharma OTC Anti-Infective Products Product
Table 112. Sun Pharma Recent Development
Table 113. CR SANJIU Company Information
Table 114. CR SANJIU Description and Business Overview
Table 115. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. CR SANJIU OTC Anti-Infective Products Product
Table 117. CR SANJIU Recent Development
Table 118. Cipla Company Information
Table 119. Cipla Description and Business Overview
Table 120. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Cipla OTC Anti-Infective Products Product
Table 122. Cipla Recent Development
Table 123. Lingrui Company Information
Table 124. Lingrui Description and Business Overview
Table 125. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Lingrui OTC Anti-Infective Products Product
Table 127. Lingrui Recent Development
Table 128. Gilead Sciences Company Information
Table 129. Gilead Sciences Description and Business Overview
Table 130. Gilead Sciences OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Gilead Sciences OTC Anti-Infective Products Product
Table 132. Gilead Sciences Recent Development
Table 133. Pfizer Company Information
Table 134. Pfizer Description and Business Overview
Table 135. Pfizer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Pfizer OTC Anti-Infective Products Product
Table 137. Pfizer Recent Development
Table 138. Bausch Health Company Information
Table 139. Bausch Health Description and Business Overview
Table 140. Bausch Health OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Bausch Health OTC Anti-Infective Products Product
Table 142. Bausch Health Recent Development
Table 143. Astellas Pharma Company Information
Table 144. Astellas Pharma Description and Business Overview
Table 145. Astellas Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Astellas Pharma OTC Anti-Infective Products Product
Table 147. Astellas Pharma Recent Development
Table 148. Roche Company Information
Table 149. Roche Description and Business Overview
Table 150. Roche OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Roche OTC Anti-Infective Products Product
Table 152. Roche Recent Development
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. OTC Anti-Infective Products Distributors List
Table 156. OTC Anti-Infective Products Customers List
Table 157. OTC Anti-Infective Products Market Trends
Table 158. OTC Anti-Infective Products Market Drivers
Table 159. OTC Anti-Infective Products Market Challenges
Table 160. OTC Anti-Infective Products Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. OTC Anti-Infective Products Product Picture
Figure 2. Global OTC Anti-Infective Products Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global OTC Anti-Infective Products Sales Market Share by Type in 2024 & 2031
Figure 4. Antifungal Product Picture
Figure 5. Antibacterial Product Picture
Figure 6. Antiviral Product Picture
Figure 7. Antiseptics Product Picture
Figure 8. Others Product Picture
Figure 9. Global OTC Anti-Infective Products Sales (US$ Million) by Sales Channel (2020 & 2024 & 2031)
Figure 10. Global OTC Anti-Infective Products Sales Market Share by Sales Channel in 2024 & 2031
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global OTC Anti-Infective Products Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global OTC Anti-Infective Products Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global OTC Anti-Infective Products Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 18. OTC Anti-Infective Products Report Years Considered
Figure 19. Global Market OTC Anti-Infective Products Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global OTC Anti-Infective Products Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America OTC Anti-Infective Products Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe OTC Anti-Infective Products Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 25. China OTC Anti-Infective Products Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 27. India OTC Anti-Infective Products Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. India OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 29. Japan OTC Anti-Infective Products Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan OTC Anti-Infective Products Sales (M Units) Growth Rate (2020-2031)
Figure 31. Global OTC Anti-Infective Products Revenue Share by Type (2020-2025)
Figure 32. Global OTC Anti-Infective Products Sales Share by Type (2026-2031)
Figure 33. Global OTC Anti-Infective Products Revenue Share by Type (2026-2031)
Figure 34. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2020-2025)
Figure 35. Global OTC Anti-Infective Products Revenue Growth Rate by Sales Channel in 2020 & 2024
Figure 36. Global OTC Anti-Infective Products Sales Share by Sales Channel (2026-2031)
Figure 37. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2026-2031)
Figure 38. Global OTC Anti-Infective Products Sales Share by Company (2024)
Figure 39. Global OTC Anti-Infective Products Revenue Share by Company (2024)
Figure 40. Global 5 Largest OTC Anti-Infective Products Players Market Share by Revenue in OTC Anti-Infective Products: 2020 & 2024
Figure 41. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 42. Manufacturing Cost Structure of OTC Anti-Infective Products
Figure 43. Manufacturing Process Analysis of OTC Anti-Infective Products
Figure 44. OTC Anti-Infective Products Industrial Chain
Figure 45. Channels of Distribution (Direct Vs Distribution)
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
